ArticleCell death discovery2024

miR-218-5p and doxorubicin combination enhances anticancer activity in breast cancer cells through Parkin-dependent mitophagy inhibition.

Francesco Davide Naso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.